Article
Community and hospital spread of Escherichia coli producing CTX-M extended-spectrum beta-lactamases in the UK.
The Journal of antimicrobial chemotherapy - 1 Oct 2004
Woodford N, Ward M E, Kaufmann M E, Turton J, Fagan E J, James D, Johnson A P, Pike R, Warner M, Cheasty T, Pearson A, Harry S, Leach J B, Loughrey A, Lowes J A, Warren R E, Livermore D M
Abstract excerpt
OBJECTIVES: During 2003, the Health Protection Agency's Antibiotic Resistance Monitoring and Reference Laboratory began to receive isolates of Escherichia coli for confirmation of extended-spectrum beta-lactamase production with a phenotype implying a CTX-M-type beta-lactamase, i.e. MICs of cefotaxime > or = 8-fold higher than MICs of ceftazidime. Many were referred as being from community patients. We examined...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
